parkinson"s disease造句
31. Severe Parkinson's disease treated with intracerebral transplantation of infant adrenal medulla have clinical significance and popularizing value.
32. Parkinson's disease is one of the commonest afflictions caused by damage cells of the brain.
33. Conclusions The study showed that apoptosis was a main death mode of nigral neuronal cells in 6 OHDA induced PD model rats, which may play a key role in the development of Parkinson's disease.
34. For Parkinson's disease, pallidotomy is revised, grafting of neural tissue is still active and DBS is added to the therapy without lesion.
35. It's hard to find much wrong with a drug that can battle fatigue and improve creativity and could even help prevent Parkinson's disease and diabetes.
36. Conclusion Co-transfer of TH and AADC cdna into the striatum is a valuable strategy to gene therapy for Parkinson's disease.
37. There are alternative therapies available for Parkinson's disease, including three other dopamine agonists that have not been associated with valvular heart disease.
38. More recent experiments have shown that fresh tissue derived in this manner can alleviate the symptoms of Parkinson's disease and sickle-cell anemia in mouse models.
39. Objective To evaluate the effect of bilateral subthalamic nuclei deep brain stimulation (STN-DBS) on anxiety and depression of patients with Parkinson's disease(PD).
40. CHICAGO an over - the - counter dieta the progression of Parkinson's disease.
41. To explore the Etiology, Pathogenesis and Treatment of TCM by the theory homogeny of liver and kidney for Parkinson's disease.
42. "Parkinson's disease (PD) starts with movement problems, " says Dr. Rosales who describes the condition as a "burning topic in neurology."
43. Objective To investigate the roles of glutamate carriers and complex of mitochondria in the pathogenesy of Parkinson's disease.
44. Objective To investigate the mechanism and summary the clinical experience of Parkinson's disease (PD) treated with deep brain stimulation (DBS) of the bi-lateral subthalamic nucleus (STN).
45. The role of the neurotransmitter acetylcholine may ultimately suggest new Parkinson's disease treatments.
46. Deep brain stimulation is used to treat conditions including Parkinson's disease , essential tremor, and multiple sclerosis .
47. Objective: Treatment with ergot-derived dopamine agonists, pergolide, and cabergoline has been associated with an increased frequency of valvular heart disease in Parkinson's disease.
48. Parkinson's disease is a degenerative disorder, which attacks parts of the brain that control movement.
49. To launch the 23andMe Parkinson's initiative, the organizers publically invited anyone with Parkinson's disease to participate.
50. Background Ergot-derived dopamine receptor agonists, often used in the treatment of Parkinson's disease, have been associated with an increased risk of valvular heart disease.
51. Parkinson's Disease : Parkinson's disease is a progressive neurological disease that affects movement and muscle control.
52. Objective To study the mechanism of dopaminergic neuronal death in substantia nigra of Parkinson's disease (PD).
53. Continuous dopaminergic drug delivery is an unmet medical need in advanced Parkinson's disease.
54. Objective To study the long-term effects of deep brain stimulation(DBS)of bilateral subthalamic nuclei(STN)on depressive disorder in Parkinson's disease(PD)and to discuss its neurological mechanism.
55. Their physical changes were caused by a sickness known as Parkinson's disease.
56. Parkinson's disease destroys the brain's nerve cells responsible for muscle control.
57. But it could also make it easier to treat Parkinson's disease, motor neurone disease and muscular dystrophy.
57.try its best to collect and build good sentences.
58. Neurostimulators are already approved to treat conditions such as Parkinson's disease, essential tremor, and dystonia, as well as obsessive compulsive disorder.
59. The FDA has already approved DBS as a treatment for neurologic disorders, including essential tremor, Parkinson's disease, dystonia, and severe obsessive-compulsive disorder.
60. One exciting outcome of the study was that participants formed tight-knit groups in the online community based on their common experience with Parkinson's disease.
123